KDM3A is expressed in BCa tissue and it has been reported following study of The Cancer Genome Atlas (TCGA) human breast cancer database (n = 729) that patients with BCa expressing high levels of KDM3A had a 3-fold increased risk of death than those with normal or low KDM3A expressing disease (43). This evidence concerns the gene KDM3A and breast carcinoma.